mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0006 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.05 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |